Abstract:The CRISPR system is an adaptive defense mechanism used by bacteria and archaea against viruses and plasmids. The discovery of the CRISPR‐associated protein Cas9 and its RNA‐guided cleavage mechanism marked the beginning of a new era in genomic engineering by enabling the editing of a target region in the genome. Gene‐edited cells or mice can be used as models for understanding human diseases. Given its high impact in functional genomic experiments on different model systems, several CRISPR/Cas9 protocols have been generated in the past years. The technique uses a straightforward "cut and stitch" mechanism, but requires an accurate step‐by‐step design. One of the key points is the use of an efficient programmable guide RNA to increase the rate of success in obtaining gene‐specific edited clones. Here, we describe an efficient editing protocol using a ribonucleotide protein (RNP) complex for homology‐directed repair (HDR)–based correction of a point mutation in an induced pluripotent stem cell (iPSC) line generated from a 14‐year‐old patient with severe early‐onset obesity carrying a de novo variant of ARNT2. The resulting isogenic iPSC line, named CUIMCi003‐A‐1, has a normal karyotype, expresses stemness markers, and can be differentiated into progenies from all three germ layers. We provide a detailed workflow for designing a single guide RNA and donor DNA, and for isolating clonal human iPSCs edited with the desired modification. This article also focuses on parameters to consider when selecting reagents for CRISPR/Cas9 gene editing after testing their efficiency with in silico tools. © 2022 The Authors. Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Design of sgRNAs and PCR primers Basic Protocol 2: Testing the efficiency of sgRNAs Basic Protocol 3: Design of template or donor DNA Basic Protocol 4: Targeted gene editing Basic Protocol 5: Selection of positive clones Basic Protocol 6: Freezing, thawing, and expansion of cells Basic Protocol 7: Characterization of edited cell lines

Generation of Human Isogenic Induced Pluripotent Stem Cell Lines with CRISPR Prime Editing

Genome Editing of Isogenic Human Induced Pluripotent Stem Cells Recapitulates Long QT Phenotype for Drug Testing.

Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors

Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9

An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing

Highly efficient generation of isogenic pluripotent stem cell models using prime editing

A Cell-Based Optimised Approach for Rapid and Efficient Gene Editing of Human Pluripotent Stem Cells

A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells

A robust and inducible precise genome editing via an all-in-one prime editor in human pluripotent stem cells

Efficient Cas9‐based Genome Editing Using CRISPR Analysis Webtools in Severe Early‐onset‐obesity Patient‐derived iPSCs

Development of an efficient single-cell cloning and expansion strategy for genome edited induced pluripotent stem cells

Near 100% genome editing efficiency with a one-step all RNA prime editing system in a human reporter iPSC line

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Enrichment of Allelic Editing Outcomes by Prime Editing in Induced Pluripotent Stem Cells

Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones

CRISPR Base Editing to Create Potential Charcot–Marie–Tooth Disease Models with High Editing Efficiency: Human Induced Pluripotent Stem Cell Harboring SH3TC2 Variants

A high efficiency precision genome editing method with CRISPR in iPSCs

A selectable all-in-one CRISPR prime editing piggyBac transposon allows for highly efficient gene editing in human cell lines

CRISPR single base-editing: in silico predictions to variant clonal cell lines

Crispr-Based Editing of Human Pluripotent Stem Cells for Disease Modeling

RNA-Generated and Gene-Edited Induced Pluripotent Stem Cells for Disease Modeling and Therapy